α-Glucosidase inhibitory activity and cytotoxic effects of some cyclic urea and carbamate derivatives

References

• Broichhagen J, Schönberger M, Cork SC, et al. Optical control of insulin release using a photoswitchable sulfonylurea. Nat Commun 2014;5:5116–26.
   PubMed Web of Science ®Google Scholar
• Mehanna A. Antidiabetic agents: past, present and future. Future Med Chem 2013;5:411–30.
   PubMed Web of Science ®Google Scholar
• Maity S, Mukherjee K, Banerjee A, et al. Inhibition of porcine pancreatic amylase activity by sulfamethoxazole: structural and functional aspect. Protein J 2016;35:237–46.
   PubMed Web of Science ®Google Scholar
• Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005;65:385–411.
   PubMed Web of Science ®Google Scholar
• LaLiberte BK, Neumiller JJ. Review of medications used in the treatment of diabetes mellitus. J Pharm Technol 2010;26:136–46.
   Google Scholar
• Lefèbvre PJ, Paquot N, Scheen AJ. Inhibiting or antagonizing glucagon: making progress in diabetes care. Diabetes Obes Metab 2015;17:720–5.
   PubMed Web of Science ®Google Scholar
• Patil P, Mandal S, Kumar Tomar S, Anand S. Food protein-derived bioactive peptides in management of type 2 diabetes. Eur J Nutr 2015;54:863–80.
   PubMed Web of Science ®Google Scholar
• Panahi F, Yousefi R, Mehraban MH, Khalafi-Nezhad A. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors. Carbohyd Res 2013;380:81–91.
   PubMed Web of Science ®Google Scholar
• Borges de Melo E, da Silveira Gomes A, Carvalho I. α- and β-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 2006;62:10277–302.
   Web of Science ®Google Scholar
• Asano N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 2003;13:93R–104R.
   PubMed Web of Science ®Google Scholar
• Taha M, Ismail NH, Imran S, et al. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methyl benzimidazoles. Bioorg Chem 2016;65:100–9.
   PubMed Web of Science ®Google Scholar
• Zawawi NKNA, Taha M, Ahmat N, et al. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies. Bioorg Chem 2016;64:29–36.
   PubMed Web of Science ®Google Scholar
• Kashtoh H, Muhammad MT, Khan JJA, et al. Dihydropyrano [2,3-c]pyrazole: novel in vitro inhibitors of yeast α-glucosidase. Bioorg Chem 2016;65:61–72.
   PubMed Web of Science ®Google Scholar
• Sato K, Sugimoto H, Rikimaru K, et al. Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists. Bioorgan Med Chem 2014;22:1649–66.
   PubMed Web of Science ®Google Scholar
• Jevtić II, Došen Mićović Lj, Ivanović ER, Ivanović MD. Hofmann rearrangement of carboxamides mediated by N-bromoacetamide. Synthesis 2016;48:1550–60.
   Web of Science ®Google Scholar
• Bogolubsky AV, Ryabukhin SV, Pipko SE, et al. A facile synthesis of unsymmetrical ureas. Tetrahedron 2011;67:3619–23.
   Web of Science ®Google Scholar
• Torrico-Vallejos S, Erben MF, et al. Convenient synthesis of carbamates, S-alkyl thiocarbamates, and N,N'-disubstituted urea derivatives of methoxycarbonylsulfenyl isocyanate. Tetrahedron Lett 2011;52:5352–4.
   Web of Science ®Google Scholar
• Bar-Am O, Weinreb O, Amit T, Youdim MBH. The novel cholinesterase–monoamine oxidase inhibitor and antioxidant, Ladostigil, confers neuroprotection in neuroblastoma cells and aged rats. J Mol Neurosci 2009;37:135–45.
   PubMed Web of Science ®Google Scholar
• Weinreb O, Amit T, Bar-Am O, Youdim MBH. A novel anti-Alzheimer’s disease drug, Ladostigil: neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor. Int Rev Neurobiol 2011;100:191–215.
   PubMed Web of Science ®Google Scholar
• Khatri M, Rai SK, Ranbhor R, et al. [(4-Arylpiperazin-1-yl)-alkyl]-carbamic acid ethyl ester derivatives as potential anxiolytic agents. Arch Pharm Res 2012;35:1143–52.
   PubMed Web of Science ®Google Scholar
• Hen N, Bialer M, Yagen B. Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates. J Med Chem 2012; 55:2835–45.
   PubMed Web of Science ®Google Scholar
• Vacondio F, Silva C, Lodola A, et al. Structure–property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability. ChemMedChem 2009;4:1495–504.
   PubMed Web of Science ®Google Scholar
• Chaudhaery SS, Roy KK, Shakya N, et al. Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology. J Med Chem 2010;53:6490–505.
   PubMed Web of Science ®Google Scholar
• Tang L-J, Liu D-W, Qin S-L, et al. Study on synthesis of (R)-tert-butylbenzyl(1-((tert-butyldimethylsilyl)oxy)but-3-yn-2-yl) carbamate. Adv Mater Res 2014;1033–34:592–95.
   Google Scholar
• Lam PYS, Jadhav PK, Aldrich PE, et al. Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2′ structure-activity relationship, and molecular recognition of cyclic ureas. J Med Chem 1996;39:3514–25.
   PubMed Web of Science ®Google Scholar
• Rodgers JD, Johnson BL, Wang H, et al. Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups. Bioorg Med Chem Lett 1998;8:715–20.
   PubMed Web of Science ®Google Scholar
• McCue P, Kwon YI, Shetty K. Anti-amylase, anti-glucosidase and anti angiotensin I converting enzyme potential of selected foods. J Food Biochem 2005;29:278–94.
   Web of Science ®Google Scholar
• Marković V, Debeljak N, Stanojković T, et al. Anthraquinone–chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies. Eur J Med Chem 2015;89:401–10.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;6:55–63.
   Web of Science ®Google Scholar
• Ohno M, Abe T. Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). J Immunol Methods 1991;145:199–203.
   PubMed Web of Science ®Google Scholar
• Matić IZ, Aljančić I, Žižak Ž, et al. In vitro antitumor actions of extracts from endemic plant Helichrysum zivojinii. BMC Complement Altern Med 2013;13:36–47.
   PubMed Web of Science ®Google Scholar
• Rocha GB, Freire RO, Simas AM. Stewart JJP. RM1: a reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I. J Comput Chem 2006;27:1101–11.
   PubMed Web of Science ®Google Scholar
• Šegan S, Opsenica I, Zlatović M, Milojković-Opsenica D, Šolaja B. Quantitative structure retention/activity relationships of biologically relevant 4-amino-7-chloroquinoline based compounds. J Chromatogr B 2016;1012:144–52.
   PubMed Web of Science ®Google Scholar
• Das J, Lin J, Moquin RV, et al. Molecular design, synthesis, and structure–activity relationships leading to the potent and selective P56lck inhibitor BMS-243117. Bioorg Med Chem Lett 2003;13:2145–9.
   PubMed Web of Science ®Google Scholar
• Li H-Q, Lv P-C, Yan T, Zhu H-L. Urea derivatives as anticancer agents, anticancer agents in medicinal chemistry. Anti-Cancer Agent Me 2009;9:471–80.
   PubMed Web of Science ®Google Scholar
• Lee H, Kim D-G, Banskota S, et al. Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis andantiangiogenic activities. Org Biomol Chem 2014;12:8702–10.
   PubMed Web of Science ®Google Scholar
• Ghasemi J, Saaidpour S. QSAR prediction of the chromatographic retention behavior of painkiller drugs. J Chromatogr Sci 2009;47:156–63.
   PubMed Web of Science ®Google Scholar
• Kouskoura MG, Kachrimanisb KG, Markopoulou CK. Modeling the drugs’ passive transfer in the body based on their chromatographic behavior. J Pharmaceut Biomed 2014;100:94–102.
   PubMed Web of Science ®Google Scholar